TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 7898228

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg twice daily (with triple therapy)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Triple therapy without omeprazole
Number of subjects: 108
Study: 2622545

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Thiopentone
Number of subjects: 40
Study: 71495

Group type: EXPERIMENTAL
Intervention: Fibre-free juice
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Fibre-disrupted purée
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Intact apples
Number of subjects: 10
Study: 30893121

Group type: EXPERIMENTAL
Intervention: Intravenous induction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Inhalational induction
Number of subjects: 0
Study: 27549867

Group type: EXPERIMENTAL
Intervention: Dutasteride 0.5 mg daily for 24 weeks
Number of subjects: 90

Group type: COMPARATOR
Intervention: Finasteride 1 mg daily for 24 weeks
Number of subjects: 90
Study: 25533393

Group type: EXPERIMENTAL
Intervention: Supplemental behavioral economic intervention (SFAS)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Education control (EDU)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Baseline values and change in RV
Number of subjects: 97
Study: 23605225

Group type: EXPERIMENTAL
Intervention: Neurofeedback treatment (30 sessions)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Usual maintenance treatment (Methadone or Buprenorphine)
Number of subjects: 20
Study: 21832112

Group type: EXPERIMENTAL
Intervention: Soybean oil-based lipid emulsion (Intralipid)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Olive oil-based lipid emulsion (ClinOleic)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Lipid free PN
Number of subjects: 12

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 12

Group type: COMPARATOR
Intervention: Soybean oil PN, olive oil PN, and lipid free PN
Number of subjects: 12
Study: 19626391

Group type: COMPARATOR
Intervention: 3 mg/kg infliximab
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 10 mg/kg infliximab
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both groups (3 mg/kg and 10 mg/kg infliximab)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher trough serum infliximab level
Number of subjects: 0
Study: 17605449

Group type: EXPERIMENTAL
Intervention: Heel stick procedure
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sham procedure (heel preparation with no heel puncture)
Number of subjects: 10
Study: 15475488

Group type: EXPERIMENTAL
Intervention: Sildenafil, 50 mg
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 11319664

Group type: EXPERIMENTAL
Intervention: Higher levels of baseline total, flexible and rigid dietary restraint
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Baseline restraint measures
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increases in restraint over the follow-up period
Number of subjects: 0
Study: 9842184

Group type: EXPERIMENTAL
Intervention: Benecol margarine (cholesterol-lowering margarine with sitostanol ester)
Number of subjects: 0
Study: 7989974

Group type: EXPERIMENTAL
Intervention: Continuous ventricular function monitor with a cadmium telluride detector (CdTe‐VEST) during supine ergometric exercise
Number of subjects: 41
Study: 3058796

Group type: EXPERIMENTAL
Intervention: Low-Na/High-K dietary salt
Number of subjects: 358

Group type: COMPARATOR
Intervention: Common salt
Number of subjects: 358
Study: 30168731

Group type: COMPARATOR
Intervention: Sildenafil (50 mg acute dose)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sildenafil (20 mg/day for 4 weeks)
Number of subjects: 0
Study: 28031082

Group type: EXPERIMENTAL
Intervention: Low dose alendronate (70 mg per two weeks)
Number of subjects: 639

Group type: EXPERIMENTAL
Intervention: Standard dose alendronate (70 mg weekly)
Number of subjects: 639

Group type: COMPARATOR
Intervention: Low dose and standard dose alendronate
Number of subjects: 639
Study: 25645267

Group type: EXPERIMENTAL
Intervention: Dermatologist's feedback on digital images of skin lesions
Number of subjects: 30

Group type: COMPARATOR
Intervention: Feedback category 1 (no further investigation)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Feedback category 3 (biopsy)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Feedback category 2 (clinical observation)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Feedback category 4 (other)
Number of subjects: 30
Study: 24351994

Group type: EXPERIMENTAL
Intervention: Cultural competence improvement program using case-based small group learning (n=31)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group (n=36)
Number of subjects: 67
Study: 20685525

Group type: EXPERIMENTAL
Intervention: Extraction therapy (4 premolar extractions)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Nonextraction treatment with air-rotor stripping (ARS)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Both groups (extraction and nonextraction)
Number of subjects: 26
Study: 17995982

Group type: EXPERIMENTAL
Intervention: PRP plus intravitreal injection of 1.5 mg of bevacizumab
Number of subjects: 30

Group type: COMPARATOR
Intervention: PRP
Number of subjects: 30
Study: 16009290

Group type: EXPERIMENTAL
Intervention: Nurse-based outpatient clinic follow-up (intervention group)
Number of subjects: 208

Group type: COMPARATOR
Intervention: Primary healthcare follow-up (control group)
Number of subjects: 208
Study: 12813449

Group type: EXPERIMENTAL
Intervention: rhTPO 1.5 microg/kg on days 1, 3, and 5 before G-CSF
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: rhTPO 0.5 microg/kg on all 3 treatment days
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: rhTPO treatment
Number of subjects: 134

Group type: COMPARATOR
Intervention: Placebo on days 1, 3, and 5 with G-CSF 5 microg/kg/day
Number of subjects: 134
Study: 10564413

Group type: EXPERIMENTAL
Intervention: Intensified primary care
Number of subjects: 527

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 527
Study: 7474048

Group type: EXPERIMENTAL
Intervention: Autogenic and imagery training (AT+IT)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Music and imagery training (M+IT)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Autogenic, music and imagery training (AT+M+IT)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Biofeedback (with all treatment groups)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Soft music (as a relaxation technique)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 39
Study: 1754795

Group type: EXPERIMENTAL
Intervention: Antimicrobial prophylaxis
Number of subjects: 0
Study: 6755768

Group type: EXPERIMENTAL
Intervention: Furosemide 40 mg at 07h00, 13h00, and 19h00
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo at 07h00, 13h00, and 19h00
Number of subjects: 12
Study: 30999080

Group type: EXPERIMENTAL
Intervention: PHT‐NLC‐hydrogel (0.5%w/v)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Phenytoin hydrogel (0.5%w/v)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Blank hydrogel
Number of subjects: 27
Study: 30241499

Group type: EXPERIMENTAL
Intervention: Nurse-led, telephone-based follow-up
Number of subjects: 871
Study: 26646464

Group type: EXPERIMENTAL
Intervention: Cardiohelp system (Maquet Cardiopulmonary AG)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Dideco ECC.O5 (Sorin Group)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Deltastream system with Hilite 7000 LT + DP3 pumphead (Medos Medizintechnik AG)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Overall extracorporeal membrane oxygenation therapy
Number of subjects: 54
Study: 25035759

Group type: EXPERIMENTAL
Intervention: Verbal report provided by a research assistant (RA) to EPs after paramedics reported to the triage nurse.
Number of subjects: 279
Study: 23572490

Group type: EXPERIMENTAL
Intervention: Acetylcysteine 1200 mg
Number of subjects: 1395

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 1395
Study: 20617358

Group type: EXPERIMENTAL
Intervention: Tocilizumab (TCZ) treatment for 24 weeks
Number of subjects: 0
Study: 17705083

Group type: EXPERIMENTAL
Intervention: Gasless laparoscopy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Minilaparotomy
Number of subjects: 100
Study: 16368821

Group type: EXPERIMENTAL
Intervention: 0.3 mg/kg succinylcholine
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg succinylcholine
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: 1.0 mg/kg succinylcholine
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: 1.5 mg/kg succinylcholine
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: 2.0 mg/kg succinylcholine
Number of subjects: 180

Group type: COMPARATOR
Intervention: saline solution (control group)
Number of subjects: 180
Study: 12740693

Group type: EXPERIMENTAL
Intervention: Brilliant Dentin and Estilux Posterior for fillings and inlays; SR‐Isosit for inlays only
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 28
Study: 10678346

Group type: EXPERIMENTAL
Intervention: Lignocaine (10 mg) and methylprednisolone (40 mg) injection
Number of subjects: 60

Group type: COMPARATOR
Intervention: Lignocaine (10 mg) injection only
Number of subjects: 60
Study: 8644684

Group type: EXPERIMENTAL
Intervention: Lauric acid diet
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Palmitic acid diet
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 32
Study: 8287989

Group type: EXPERIMENTAL
Intervention: Betaxolol
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Pilocarpine
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group (20 patients)
Number of subjects: 52
Study: 3524471

Group type: EXPERIMENTAL
Intervention: Intralesional alpha 2-interferon (IFN) 5 X 10(5) IU per dose, nine injections
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Intralesional alpha 2-interferon (IFN) 1 X 10(5) IU per injection
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Intralesional alpha 2-interferon (IFN) 1 X 10(4) IU per injection
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Intralesional alpha 2-interferon (IFN) 5 X 10(5) IU per injection, minimum of six injections
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo injections
Number of subjects: 27
Study: 31679866

Group type: EXPERIMENTAL
Intervention: Zoster Vaccine Live (ZVL)
Number of subjects: 981

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 981
Study: 30459054

Group type: EXPERIMENTAL
Intervention: Low-fat diet
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Mediterranean diet
Number of subjects: 28
Study: 27778367

Group type: EXPERIMENTAL
Intervention: GR-MD-02 (galectin-3 inhibitor)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 25058414

Group type: EXPERIMENTAL
Intervention: Speeded intentionality judgments about grammatical subjects
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Unspeeded intentionality judgments about grammatical subjects
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intentionality judgments about grammatical subjects and objects in partially symmetric sentences
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Encouraged reflection on events described by sentences
Number of subjects: 0
Study: 24711548

Group type: EXPERIMENTAL
Intervention: PINAOS (overall survival index)
Number of subjects: 572

Group type: EXPERIMENTAL
Intervention: PINARFS (relapse-free survival index)
Number of subjects: 572
Study: 22062774

Group type: EXPERIMENTAL
Intervention: Conventional verbal information plus second‐grade reading level brochure (Group 2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Conventional verbal information plus American Academy of Ophthalmology DVD (Group 4)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional verbal information (Group 1)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional verbal information plus eighth‐grade reading level brochure (Group 3)
Number of subjects: 0
Study: 21056263

Group type: EXPERIMENTAL
Intervention: Zoledronic Acid (ZOL) 4 mg
Number of subjects: 422

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 422
Study: 17444041

Group type: EXPERIMENTAL
Intervention: PPV combined with intravitreous antibiotic drugs
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: PPV combined with silicone oil tamponade
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 30
Study: 16336695

Group type: EXPERIMENTAL
Intervention: SNPs in the IL4 gene haplotypes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Variation in the IL13 gene
Number of subjects: 0

Group type: COMPARATOR
Intervention: Single SNPs in conserved non-coding elements
Number of subjects: 0
Study: 12465659

Group type: EXPERIMENTAL
Intervention: 7 Hz-modulated 450 MHz electromagnetic radiation (10-20 min, 0.158 mW cm(‐2))
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sham-exposed group
Number of subjects: 100
Study: 10215750

Group type: EXPERIMENTAL
Intervention: Ceftibuten (9 mg kg(‐1))
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Cefixime (8 mg kg(‐1))
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Azithromycin (10 mg kg(‐1))
Number of subjects: 50
Study: 8885951

Group type: EXPERIMENTAL
Intervention: Low-dose indomethacin
Number of subjects: 431

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 431
Study: 1950147

Group type: EXPERIMENTAL
Intervention: Cocktail group (100 ml of fluorescein mixture)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Fraction group (10 ml isolated fluorescein)
Number of subjects: 10
Study: 6338906

Group type: EXPERIMENTAL
Intervention: pindolol 0.25%
Number of subjects: 28

Group type: COMPARATOR
Intervention: timolol 0.5%
Number of subjects: 28
Study: 30626354

Group type: EXPERIMENTAL
Intervention: Ocular bandage contact lens (BCL)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 60
Study: 29766165

Group type: EXPERIMENTAL
Intervention: EPA supplementation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: LIP supplementation
Number of subjects: 0
Study: 27580080

Group type: EXPERIMENTAL
Intervention: Wedged insole group
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 48
Study: 24183818

Group type: EXPERIMENTAL
Intervention: d-cycloserine (DCS) 50 mg
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67

Group type: COMPARATOR
Intervention: Both DCS and Placebo
Number of subjects: 67
Study: 22779378

Group type: EXPERIMENTAL
Intervention: Oral health education interventions (sample bag and/or video)
Number of subjects: 611

Group type: EXPERIMENTAL
Intervention: Video intervention
Number of subjects: 611

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 611
Study: 21131257

Group type: EXPERIMENTAL
Intervention: Simulator-based driving-related training
Number of subjects: 69

Group type: COMPARATOR
Intervention: Non-computer-based cognitive training
Number of subjects: 69
Study: 17931065

Group type: EXPERIMENTAL
Intervention: HC‐SSW‐UVB (highly concentrated saline spa water baths followed by UVB)
Number of subjects: 160

Group type: COMPARATOR
Intervention: UVB only
Number of subjects: 160
Study: 15902792

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard oxygen treatment
Number of subjects: 0
Study: 12479025

Group type: EXPERIMENTAL
Intervention: Seroxat 20 mg daily for four weeks
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Post-treatment observation after stopping Seroxat
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Side effects of Seroxat
Number of subjects: 43
Study: 9805695

Group type: EXPERIMENTAL
Intervention: Epidural fentanyl with 0.5% lidocaine (Group L + F) at doses of 0, 0.3, 1, 3, and 5 micrograms/kg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Epidural fentanyl alone (Group F) at doses of 1, 3, and 5 micrograms/kg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Epidural fentanyl 3 micrograms/kg with 0.5% lidocaine
Number of subjects: 40
Study: 7714348

Group type: EXPERIMENTAL
Intervention: 200 mg controlled-release morphine sulfate tablet
Number of subjects: 25

Group type: COMPARATOR
Intervention: 100 mg controlled-release morphine sulfate tablet
Number of subjects: 25
Study: 1524367

Group type: EXPERIMENTAL
Intervention: 100 micrograms/ml rPDGF-BB
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 6343860

Group type: EXPERIMENTAL
Intervention: Ribavirin
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 31667483

Group type: EXPERIMENTAL
Intervention: Crocetin (10 mg per day)
Number of subjects: 50
Study: 30239784

Group type: EXPERIMENTAL
Intervention: Freeze-only strategy
Number of subjects: 782

Group type: COMPARATOR
Intervention: Fresh embryo transfer (ET) strategy
Number of subjects: 782

Group type: COMPARATOR
Intervention: Fresh ET strategy
Number of subjects: 782
Study: 27042964

Group type: EXPERIMENTAL
Intervention: Cryoballoon ablation
Number of subjects: 762

Group type: COMPARATOR
Intervention: Radiofrequency ablation
Number of subjects: 762
Study: 24055627

Group type: EXPERIMENTAL
Intervention: Rhodiola rosea (RR) supplementation (600mg/day)
Number of subjects: 48
Study: 22036839

Group type: EXPERIMENTAL
Intervention: ICP-targeted therapy with CM monitoring
Number of subjects: 60

Group type: COMPARATOR
Intervention: CPP-targeted therapy
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: CM monitoring for poor outcome
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: CM monitoring for good outcome
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: ICP-targeted therapy
Number of subjects: 60
Study: 19131241

Group type: EXPERIMENTAL
Intervention: Gastrazole by continuous intravenous infusion
Number of subjects: 3

Group type: COMPARATOR
Intervention: Best supportive care or placebo
Number of subjects: 3

Group type: COMPARATOR
Intervention: 5-fluorouracil
Number of subjects: 3
Study: 17994402

Group type: EXPERIMENTAL
Intervention: Levalbuterol HFA 90 microg (two actuations of 45 microg) administered via metered dose inhaler (MDI) 30 minutes before exercise
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo administered via metered dose inhaler (MDI) 30 minutes before exercise
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Levalbuterol HFA
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 16358372

Group type: EXPERIMENTAL
Intervention: Innocor (foreign gas rebreathing method)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Thermodilution
Number of subjects: 34

Group type: COMPARATOR
Intervention: Echocardiography (CO(EC))
Number of subjects: 34

Group type: COMPARATOR
Intervention: Left ventricle radiography (CO(LVR))
Number of subjects: 34
Study: 12494136

Group type: EXPERIMENTAL
Intervention: Antihypertensive drugs (all 4 main classes)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 9876338

Group type: COMPARATOR
Intervention: 100 mg daily dose of DHEA for 6 months
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Placebo for 6 months
Number of subjects: 19
Study: 7647820

Group type: EXPERIMENTAL
Intervention: Dexfenfluramine (30 mg/day)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 112
Study: 2536868

Group type: EXPERIMENTAL
Intervention: Adjuvant surgical resection after chemotherapy
Number of subjects: 72

Group type: COMPARATOR
Intervention: No surgical resection (control group)
Number of subjects: 72
Study: 790545

Group type: EXPERIMENTAL
Intervention: Ketoprofen
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 31574589

Group type: EXPERIMENTAL
Intervention: Modified visual inhaler spacer usage guidelines
Number of subjects: 510

Group type: COMPARATOR
Intervention: Unmodified visual inhaler spacer usage guidelines
Number of subjects: 510
Study: 30256675

Group type: EXPERIMENTAL
Intervention: Visual plus tactile stimuli
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Visual, tactile plus haptic feedback stimuli
Number of subjects: 59

Group type: COMPARATOR
Intervention: Visual stimuli only
Number of subjects: 59
Study: 28235116

Group type: EXPERIMENTAL
Intervention: Music therapy plus standard care (medical and nursing care with scheduled pharmacologic pain intervention)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard care only
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Music therapy plus standard care
Number of subjects: 60
Study: 25612493

Group type: EXPERIMENTAL
Intervention: Rituximab (375 mg/m²)
Number of subjects: 280

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 280
Study: 22958426

Group type: EXPERIMENTAL
Intervention: Taspoglutide 10 mg
Number of subjects: 760

Group type: EXPERIMENTAL
Intervention: Taspoglutide 20 mg
Number of subjects: 760

Group type: COMPARATOR
Intervention: Pioglitazone 45 mg
Number of subjects: 760
Study: 21518942

Group type: EXPERIMENTAL
Intervention: Tai chi exercise program (n = 50)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Time-matched education (n = 50, control group)
Number of subjects: 100
Study: 19359536

Group type: EXPERIMENTAL
Intervention: Early invasive treatment strategy (EIS)
Number of subjects: 1128

Group type: COMPARATOR
Intervention: Selective invasive treatment strategy (SIS)
Number of subjects: 1128

Group type: EXPERIMENTAL
Intervention: Cystatin C concentration in the third quartile
Number of subjects: 1128

Group type: EXPERIMENTAL
Intervention: Cystatin C tertiles
Number of subjects: 1128
Study: 16328192

Group type: EXPERIMENTAL
Intervention: Isometric squat training (bilateral leg extension at 70% of maximum voluntary contraction for 15 s per set, 10 sets/day, 4 days/week for 12 weeks)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Isometric squat training
Number of subjects: 8
Study: 15591013

Group type: EXPERIMENTAL
Intervention: L-carnitine (2 and 4 grams per day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: L-carnitine
Number of subjects: 0
Study: 11131232

Group type: EXPERIMENTAL
Intervention: Supine position
Number of subjects: 10

Group type: COMPARATOR
Intervention: Upright position
Number of subjects: 10
Study: 9284980

Group type: EXPERIMENTAL
Intervention: Ketotifen (1 mg twice daily)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 8376471

Group type: EXPERIMENTAL
Intervention: Conversational turn‐taking
Number of subjects: 48

Group type: COMPARATOR
Intervention: Random responsiveness
Number of subjects: 48